SC directs medical board at AIIMS to evaluate MTP post 24 weeks
The Supreme Court has directed AIIMS, New Delhi, to form a medical board to evaluate the condition of a woman seeking to terminate her over 24-week pregnancy due to medical concerns, including postpartum depression. A further hearing is scheduled for October 9. The woman's appeal directly to the apex court has raised questions, given the 24-week limit for abortion as per the MTP Act.
New Delhi: The Supreme Court on Thursday asked the All India Institute of Medical Sciences (AIIMS), New Delhi, to constitute a medical board to assess the medical condition of a woman, who is over 24-week pregnant and is seeking permission to terminate it.The woman, who is married and already has two children, has moved the apex court seeking its approval to terminate her pregnancy citing...
New Delhi: The Supreme Court on Thursday asked the All India Institute of Medical Sciences (AIIMS), New Delhi, to constitute a medical board to assess the medical condition of a woman, who is over 24-week pregnant and is seeking permission to terminate it.
The woman, who is married and already has two children, has moved the apex court seeking its approval to terminate her pregnancy citing medical grounds, including that she is suffering from postpartum depression.
Also Read:SC allows rape survivor to terminate pregnancy, Raps Gujarat High Court
A bench of Justices Hima Kohli and B V Nagarathna asked the Delhi-based woman to present herself before the medical board on Friday.
It has posted the matter for further hearing on October 9.
During the hearing, the bench questioned the petitioner’s counsel as to why he directly approached the apex court instead of moving the Delhi High Court.
The counsel said the woman came to know about her pregnancy at a belated stage and now she was in her 25th week of pregnancy.
Under the Medical Termination of Pregnancy (MTP) Act, the upper limit for the termination of pregnancy is 24 weeks for married women, special categories including survivors of rape, and other vulnerable women such as the differently-abled and minors.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd